The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%. 

Rheinmetall cut its 2026 outlook for the second time in three months, citing delays to German military projects and artillery ammunition deliveries.

Following a dramatic plunge in its stock price, IREN said some revenue is being delayed from 2026 until early next year.

The stock rose more than 1% Thursday during Wall Street's sell-off.

Companies tied to the AI buildout are all selling off as concerns mount about a slowdown following the midterm elections.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Figma is letting clients use more artificial intelligence features for the same price. The company would like the move to boost results in the long term.

The drug distributor also raised its full-year earnings guidance.

Sales of Nintendo's flagship Switch 2 plunged in its fiscal second quarter after the Japanese gaming giant rolled out price hikes amid soaring memory costs.

Qualcomm delivered better-than-expected results but issued a weak earnings forecast.

E.l.f. Beauty posted stronger-than-expected quarterly results on Wednesday as the company continues to see broad-based growth across its portfolio.

Wayfair said its sales jumped 10% in the third quarter as the retailer posted its strongest quarter since the pandemic.

McDonald's has leaned into discounts to attract budget-conscious diners over the last two years.

Flutter's new CEO Dan Taylor issued his first earnings report as CEO on Wednesday.

Qnity's third quarter was strong across the board and so what its full-year guide.

Kraft Heinz will divest its North American coffee business to private equity firm One Rock Capital Partners as CEO Steve Cahillane works to revive the company.

Uber reported better-than-expected revenue but its mobility unit faced higher fuel costs overseas and tighter driver supply.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

AMD reported better-than-expected third-quarter results, driven by booming sales of AI chips

Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates